Iopamidol: new preclinical and clinical data.
Iopamidol was rapidly eliminated from the central nervous system of dogs (greater than 90% in 24 hours). In rabbits, renal excretion involved tubular mechanisms at low blood levels, and predominant glomerular filtration at higher levels. Injection of iopamidol into the right atriums of rabbits produced hemodynamic effects similar to those of other contrast media, but less severe. The effect of iopamidol on peripheral vascular resistance was significantly lower than that of metrizamide. Iopamidol was found useful in clinical neuroradiology and angiography.
D000328:Adult; D000792:Angiography; D000818:Animals; D003287:Contrast Media / Q000378:metabolism*; D003404:Creatinine / Q000378:metabolism; D004285:Dogs; D004341:Drug Evaluation; D005260:Female; D006261:Headache / Q000139:chemically induced; D006801:Humans; D007267:Injections; D007479:Iopamidol; D007483:Iothalamic Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000378:metabolism; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D009485:Neuroradiography; D011817:Rabbits; D014567:Urography; D014655:Vascular Resistance / Q000187:drug effects
D003287:Contrast Media; D007483:Iothalamic Acid; D003404:Creatinine; D007479:Iopamidol